2',3',N⁴-trilevulinyl-1-β-D-arabinofuranosylcytosine | 83200-46-8

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 嘧啶核苷
• 英文名称: 2',3',N⁴-trilevulinyl-1-β-D-arabinofuranosylcytosine
• 英文别名: [(2R,3R,4S,5R)-2-(hydroxymethyl)-5-[2-oxo-4-(4-oxopentanoylamino)pyrimidin-1-yl]-4-(4-oxopentanoyloxy)oxolan-3-yl] 4-oxopentanoate
• CAS: 83200-46-8
• 化学式: C₂₄H₃₁N₃O₁₁
• 分子量: 537.524
• InChiKey: HKIRTVNYQWNDPX-LTFXSFKNSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2.4
• 重原子数：
  38
• 可旋转键数：
  16
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.58
• 拓扑面积：
  195
• 氢给体数：
  2
• 氢受体数：
  11

反应信息

• 作为反应物：
  描述：

  2',3',N⁴-trilevulinyl-1-β-D-arabinofuranosylcytosine 在 水 作用下， 以 甲醇 、 氯仿 为溶剂， 反应 2.0h， 生成 1-β-D-arabinofuranosylcytosine 5'-monophosphate-L-1,2-dipalmitin
  参考文献：
  名称：

  Phospholipid-nucleoside conjugates. 3. Syntheses and preliminary biological evaluation of 1-.beta.-D-arabinofuranosylcytosine 5'-monophosphate-L-1,2-dipalmitin and selected 1-.beta.-D-arabinofuranosylcytosine 5'-diphosphate-L-1,2-diacylglycerols

  摘要：

  Several new phospholipid-ara-C conjugates have been prepared and tested as prodrugs of the parent ara-C. The new derivative include ara-CMP-L-dipalmitin, ara-CDP-L-distearin, ara-CDP-L dimyristin, ara-CDP-L-diolein, and the radioactively labeled derivative ara-CDP-L-di[1-14C]palmitin. In addition, the unusually stable ara-CMP-L-dipalmitin-N-phosphoryldicyclohexylurea adduct was isolated as a crystalline solid (two diastereomers) in the reaction sequence to prepare ara-CMP-L-dipalmitin. The new prodrugs were solubilized by sonication methods and tested for their antiproliferative activity in vitro against mouse myeloma MPC-11 cells and against L1210 lymphoid leukemia. Such studies demonstrated that the antiproliferative activities of the prodrugs (as determined by ED50) were less that ara-C on a molar basis. In the mouse myeloma cell line some evidence was obtained that the antiproliferative activity was related to the chain length of the fatty acid side chains in the prodrugs. In in vivo studies against L1210 lymphoid leukemia in mice, the prodrugs were shown to be much more effective than ara-C, with the overall efficacy apparently being independent of the length of the fatty acid side chain. Some evidence was obtained in the vivo studies that the ara-CDP-L-dimyristin, which bears the shortest fatty acid side chain, was more toxic at the higher dosages than the longer chain length derivatives.

  DOI：

  10.1021/jm00353a010
• 作为产物：
  描述：

  胞苷 在 吡啶 、 碳酸二苯酯 、 碳酸氢钠 、 溶剂黄146 、 N,N'-二环己基碳二亚胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 12.0h， 生成 2',3',N⁴-trilevulinyl-1-β-D-arabinofuranosylcytosine
  参考文献：
  名称：

  An Improved Synthesis of 1-β-D-Arabinofuranosylcytosine 5′-Phosphate-L-1,2-diacylglycerols

  摘要：

  5'-O-MMTr-cytosine arabinoside was prepared on a large scale from 5'-0-MMTr-cytidine with diphenyl carbonate via 5'-protected cytidine - 2',3'-carbonate -- aracytidine-2',2-anhydro derivative at a 67 % yield. The synthesis of 1,2-L-dipalmitoyl-sn-glycerol, 1,2-L-distearoyl-sn-glycerol and 1,2-L-dioleoyl-sn-glycerol described here using 9-fluorenylmethoxycarbonyl (FMOC) group for protection of 3-position of glycerol which can be selectively removed by Et3N treatment on the overall 60-70 % yield based on 1,2,-isopropilidene-sn-glycerol. These glycerols were phosphorylated first with 2-chlorophenyl-phosphoro-bis-triazolide quantitatively(1) in order to avoid acyl migration, then the glycerophosphate intermediates were condensed with 2',3',N-4-trileulinyl-1-beta-D-arabinofuranosylcytosine in the presence of 2-mesytilenesulphonyl chloride (MsCl) and 1-methylimidazole (MeIm)- which was used in the coupling of nucleotides(2)- in an 85-95 % yield compared with the low yielding diester method of Ryu(3.) Deblocking was carried out in two steps with tetrabutylammonium fluoride (TBAF) and hydrazine hydrate, producing target compouns (14a, 14b, 14c) at a 50 % yield.

  DOI：

  10.1080/07328319808004734

文献信息

• Synthesis of 1-β-d-arabinofuranosyl-cytosine 5′-phosphate-l-1,2-diacylglycerols
  作者：Ágnes Nyilas

  DOI：10.1016/s0009-3084(97)00056-x

  日期：1997.9

  5'-O-MMTr-cytosine arabinoside was prepared on a large scale from 5'-O-MMTr-cytidine with diphenyl carbonate via 5'-protected cytidine-2',3'-carbonate-ara-cytidine-2',2-anhydro derivative at a 67% yield. 1,2-Dipalmitoyl-sn-glycerol, 1,2-distearoyl-sn-glycerol and 1,2-dioleoyl-sn-glycerol were phosphorylated first with 2-chlorphenyl-phosphorobis-triazolide quantitatively (Welch and Chattopadhyaya, 1985. Acta Chem. Scand. B39, 47-57). This method was used in order to avoid acyl migration, then the glycerophosphate intermediates were condensed with 2',3',N-4-trileulinyl-1-beta-D-arabinofuranosylcytosine in the presence of 2-mesytilensulphonyl chloride (MSCI) and 1-methylimidazole (MeIm)-which was used in the coupling of nucleotides (Nyilas et al., 1986. Acta Chem. Scand. B40, 678-684)-in an 85-88% yield compared with the low yielding diester method of Ryu et al., 1982. J. Med. Chem. 25, 1322-1329. Deblocking was carried out in two steps with tetrabutylammonium fluoride (TBAF) and hydrazine hydrate, producing target compounds (9a, 9b, 9c) at a 50% yield. (C) 1997 Elsevier Science Ireland Ltd.
• An Improved Synthesis of 1-β-D-Arabinofuranosylcytosine 5′-Phosphate-L-1,2-diacylglycerols
  作者：Ágnes Nyilas

  DOI：10.1080/07328319808004734

  日期：1998.9

  5'-O-MMTr-cytosine arabinoside was prepared on a large scale from 5'-0-MMTr-cytidine with diphenyl carbonate via 5'-protected cytidine - 2',3'-carbonate -- aracytidine-2',2-anhydro derivative at a 67 % yield. The synthesis of 1,2-L-dipalmitoyl-sn-glycerol, 1,2-L-distearoyl-sn-glycerol and 1,2-L-dioleoyl-sn-glycerol described here using 9-fluorenylmethoxycarbonyl (FMOC) group for protection of 3-position of glycerol which can be selectively removed by Et3N treatment on the overall 60-70 % yield based on 1,2,-isopropilidene-sn-glycerol. These glycerols were phosphorylated first with 2-chlorophenyl-phosphoro-bis-triazolide quantitatively(1) in order to avoid acyl migration, then the glycerophosphate intermediates were condensed with 2',3',N-4-trileulinyl-1-beta-D-arabinofuranosylcytosine in the presence of 2-mesytilenesulphonyl chloride (MsCl) and 1-methylimidazole (MeIm)- which was used in the coupling of nucleotides(2)- in an 85-95 % yield compared with the low yielding diester method of Ryu(3.) Deblocking was carried out in two steps with tetrabutylammonium fluoride (TBAF) and hydrazine hydrate, producing target compouns (14a, 14b, 14c) at a 50 % yield.
• Phospholipid-nucleoside conjugates. 3. Syntheses and preliminary biological evaluation of 1-.beta.-D-arabinofuranosylcytosine 5'-monophosphate-L-1,2-dipalmitin and selected 1-.beta.-D-arabinofuranosylcytosine 5'-diphosphate-L-1,2-diacylglycerols
  作者：Eung K. Ryu、Robert J. Ross、Tatsuo Matsushita、Malcolm MacCoss、Chung I. Hong、Charles R. West

  DOI：10.1021/jm00353a010

  日期：1982.11

  Several new phospholipid-ara-C conjugates have been prepared and tested as prodrugs of the parent ara-C. The new derivative include ara-CMP-L-dipalmitin, ara-CDP-L-distearin, ara-CDP-L dimyristin, ara-CDP-L-diolein, and the radioactively labeled derivative ara-CDP-L-di[1-14C]palmitin. In addition, the unusually stable ara-CMP-L-dipalmitin-N-phosphoryldicyclohexylurea adduct was isolated as a crystalline solid (two diastereomers) in the reaction sequence to prepare ara-CMP-L-dipalmitin. The new prodrugs were solubilized by sonication methods and tested for their antiproliferative activity in vitro against mouse myeloma MPC-11 cells and against L1210 lymphoid leukemia. Such studies demonstrated that the antiproliferative activities of the prodrugs (as determined by ED50) were less that ara-C on a molar basis. In the mouse myeloma cell line some evidence was obtained that the antiproliferative activity was related to the chain length of the fatty acid side chains in the prodrugs. In in vivo studies against L1210 lymphoid leukemia in mice, the prodrugs were shown to be much more effective than ara-C, with the overall efficacy apparently being independent of the length of the fatty acid side chain. Some evidence was obtained in the vivo studies that the ara-CDP-L-dimyristin, which bears the shortest fatty acid side chain, was more toxic at the higher dosages than the longer chain length derivatives.